加州再生医学研究所独立公民监督委员会定期会议治理小组委员会。 根据加利福尼亚州干细胞研究与治疗法案组织。 将最新的 CIRM 新闻、即将召开的会议的信息以及资金机会发送到您的收件箱。

CIRM funds stem cell research to institutions throughout California. On the map below, click on any marker to learn more about our funding to that institution. You can explore the awards they’ve ...

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

At the California Institute for Regenerative Medicine (CIRM), we are committed to the continued funding of groundbreaking research in regenerative medicine. To reflect this commitment, we are ...

The California Institute for Regenerative Medicine (CIRM) was established in 2004 when 59 percent of California voters passed Proposition 71, also known as the California Stem Cell Research and Cures ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

The CIRM iPSC Repository is a collection of induced pluripotent stem cell (iPSC) lines produced from tissue samples obtained from thousands of individuals by researchers in California through funding ...

通常通过让患者在移植后继续服用抑制免疫系统正常反应的药物来预防移植器官的排斥。然而，免疫抑制（IS）对患者具有显着的长期健康影响。临床前研究表明，将供体的造血细胞注入受体，可以通过使受体的免疫系统嵌合（其中受体和供体的免疫细胞都存在 ...

The maximum total funding for a DISC4 Award is $13 million per award. The maximum award duration is four years. Applicant Core Teams must be multi-institutional and include at least five California ...